Recently, Canada’s Health Department took significant action by seizing over 11,400 bottles of injectable medications that originated from China. Alarmingly, some of the samples tested positive for bacteria that could potentially cause serious infections. These medications had not received approval from Canadian health authorities but were available for sale on local websites, where they were marketed for weight loss, muscle gain, and anti-aging effects. In light of these findings, the Health Department has issued a warning to the public against purchasing or using these products.
According to reports, the seized medications were supplied by Shanghai ERP Peptide Biotechnology Co. Ltd. in China. The Health Department disclosed that the products contained bacterial contamination, including strains like Acinetobacter baumannii, which are known to cause infections.
Health officials stressed that the use of injectable drugs contaminated with bacteria can lead to severe infections and even pose life-threatening risks. Individuals with weakened immune systems are particularly vulnerable to such threats, making the situation even more dire.
Investigations revealed that two Canadian online retailers had previously sold the medications provided by the Chinese company. These platforms were True North Bio Labs and BC Axiom Peptide, both of which are now closed following the Health Department’s intervention.
With judicial authorization, the Health Department executed the seizure of these products, ensuring that the illegal sale of unapproved peptide drugs would be halted. The two websites that sold these medications are no longer operational, and the Health Department has also instructed the Chinese supplier to cease all sales of unapproved peptide products to Canada.
Among the seized products were various compounds, including Tirzepatide, Retatrutide, MOTS-C, Tesamorelin, and NAD+. Some of these ingredients are linked to weight loss, metabolic regulation, and other medical purposes; however, none of the seized items had received approval from Canadian health authorities for sale.
In recent years, peptide products have been marketed by various online vendors as remedies for weight loss, muscle building, and anti-aging. The Health Department cautioned that unapproved injectable peptide drugs have not undergone essential scrutiny by regulatory agencies concerning their safety, effectiveness, and quality.
These products could contain drug ingredients or dosages that do not match the labels or may be tainted with bacteria, heavy metals, and other harmful substances. Aside from the risk of infections, using such medications could also lead to serious health issues, including abnormal blood sugar levels, hormonal imbalances, and liver and kidney damage.
The Health Department is actively collaborating with the Canada Border Services Agency (CBSA) to prevent such unapproved medications from entering the country.
Authorities have urged the public not to purchase or use the implicated products. Anyone who has already used them is advised to consult healthcare professionals for guidance. Furthermore, if symptoms such as fever, chills, or redness and pain at injection sites occur, individuals are encouraged to seek prompt medical attention.